StockData

Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Earnings

Nutra Pharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Nutra Pharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2010ended Jun 30, 2010Aug 6, 2010during market hours–––Filing
Q4 FY2009ended Dec 31, 2009Feb 2, 2010before the open–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Nutra Pharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Nutra Pharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Nutra Pharma filed with the SEC as exhibits to Form 8-K or 6-K

  1. 8-K exhibit EX-99.1
    Update
  2. Park of Commerce Blvd ♦ Suite 1B
    Update

See a number that looks wrong?